Anna V Eremeeva

4PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 08, 2025
[Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosis].

A N Boyko, V M Alifirova, Z A Goncharova

|Apr 27, 2024
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].

A N Boyko, V M Alifirova, I G Lukashevich

|Aug 10, 2023
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].

A N Boyko, V M Alifirova, I G Lukashevich

|Sep 29, 2021
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study.

Nikita V Lomakin, Bulat A Bakirov, Denis N Protsenko

Pageof 1

Frequent Collaborators

4 joint publications

Yulia N Linkova

4 joint publications

Arina V Zinkina-Orikhan

3 joint publications

A N Boyko

3 joint publications

V M Alifirova